| Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability AR Mohammed, N Weston, AGA Coombes, M Fitzgerald, Y Perrie International journal of pharmaceutics 285 (1-2), 23-34, 2004 | 451 | 2004 |
| Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens Y Perrie, AR Mohammed, DJ Kirby, SE McNeil, VW Bramwell International journal of pharmaceutics 364 (2), 272-280, 2008 | 449 | 2008 |
| High-strength resorbable brushite bone cement with controlled drug-releasing capabilities MP Hofmann, AR Mohammed, Y Perrie, U Gbureck, JE Barralet Acta biomaterialia 5 (1), 43-49, 2009 | 208 | 2009 |
| Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project GYH Lip, S Kamath, M Jafri, A Mohammed, D Bareford Stroke 33 (1), 238-242, 2002 | 205 | 2002 |
| Trigger release liposome systems: local and remote controlled delivery? S Bibi, E Lattmann, AR Mohammed, Y Perrie Journal of microencapsulation 29 (3), 262-276, 2012 | 183 | 2012 |
| Microscopy imaging of liposomes: From coverslips to environmental SEM S Bibi, R Kaur, M Henriksen-Lacey, SE McNeil, J Wilkhu, E Lattmann, ... International journal of pharmaceutics 417 (1-2), 138-150, 2011 | 179 | 2011 |
| The role of formulation excipients in the development of lyophilised fast-disintegrating tablets R Chandrasekhar, Z Hassan, F AlHusban, AM Smith, AR Mohammed European journal of pharmaceutics and biopharmaceutics 72 (1), 119-129, 2009 | 156 | 2009 |
| Lyophilisation and sterilisation of liposomal vaccines to produce stable and sterile products AR Mohammed, VW Bramwell, AGA Coombes, Y Perrie Methods 40 (1), 30-38, 2006 | 154 | 2006 |
| Compressed orally disintegrating tablets: excipients evolution and formulation strategies A Al-Khattawi, AR Mohammed Expert opinion on drug delivery 10 (5), 651-663, 2013 | 107 | 2013 |
| The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs MH Ali, B Moghaddam, DJ Kirby, AR Mohammed, Y Perrie International journal of pharmaceutics 453 (1), 225-232, 2013 | 103 | 2013 |
| An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low … H Alyami, E Dahmash, J Bowen, AR Mohammed PloS one 12 (6), e0178772, 2017 | 89 | 2017 |
| Application of genomics, proteomics and metabolomics in drug discovery, development and clinic C Russell, A Rahman, AR Mohammed Therapeutic delivery 4 (3), 395-413, 2013 | 89 | 2013 |
| The impact of ageing on the barriers to drug delivery Y Perrie, RKS Badhan, DJ Kirby, D Lowry, AR Mohammed, D Ouyang Journal of controlled release 161 (2), 389-398, 2012 | 84 | 2012 |
| Evaluation of anti-biofilm activity of acidic amino acids and synergy with ciprofloxacin on Staphylococcus aureus biofilms AA Warraich, AR Mohammed, Y Perrie, M Hussain, H Gibson, A Rahman Scientific Reports 10 (1), 9021, 2020 | 81 | 2020 |
| Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent MH Ali, DJ Kirby, AR Mohammed, Y Perrie Journal of pharmacy and pharmacology 62 (11), 1646-1655, 2010 | 80 | 2010 |
| The application of monolayer studies in the understanding of liposomal formulations B Moghaddam, MH Ali, J Wilkhu, DJ Kirby, AR Mohammed, Q Zheng, ... International journal of pharmaceutics 417 (1-2), 235-244, 2011 | 78 | 2011 |
| Amino acids as cryoprotectants for liposomal delivery systems AR Mohammed, AGA Coombes, Y Perrie European journal of pharmaceutical sciences 30 (5), 406-413, 2007 | 76 | 2007 |
| Delivery of poorly soluble drugs via mesoporous silica: Impact of drug overloading on release and thermal profiles TT Le, AK Elzhry Elyafi, AR Mohammed, A Al-Khattawi Pharmaceutics 11 (6), 269, 2019 | 64 | 2019 |
| Formulation and characterisation of lyophilised rapid disintegrating tablets using amino acids as matrix forming agents F AlHusban, Y Perrie, AR Mohammed European Journal of Pharmaceutics and Biopharmaceutics 75 (2), 254-262, 2010 | 60 | 2010 |
| Paediatric specific dosage forms: Patient and formulation considerations D Khan, D Kirby, S Bryson, M Shah, AR Mohammed International journal of pharmaceutics 616, 121501, 2022 | 59 | 2022 |
Muhammad Raheel AfzalR&D Project Leader, Daikin EuropeПідтверджена електронна адреса в daikineurope.com